Total raised
—
Stage
Pre-Funding
Founded
2005
Headcount
6
HQ
Karmei Yosef
Sector
Health Tech & Life Sciences
About
CapsuLINT is a pharmaceutical company that has developed a patentedoral drug delivery system. It is designed to promote dissolution, increased permeability, and improved oral absorption of low-solubility drugs and/or low-permeability drugs, in a nano-size amorphous dispersion.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is CapsuLINT's primary business?
- CapsuLINT is a pharmaceutical company focused on developing a patented oral drug delivery system designed to improve the absorption of low-solubility and/or low-permeability drugs.
- When was CapsuLINT founded?
- CapsuLINT was founded in January 2005.
- What is the current status of CapsuLINT?
- CapsuLINT is currently inactive as of December 2015.
- Where is CapsuLINT headquartered?
- CapsuLINT is headquartered in Karmei Yosef, Center District, Israel.
- How many employees does CapsuLINT have?
- CapsuLINT has 6 employees.
- Has CapsuLINT raised any funding?
- CapsuLINT has not raised any funding, maintaining a 'Pre-Funding' stage.
- Does CapsuLINT hold any patents?
- Yes, CapsuLINT holds one patent related to its oral drug delivery system.
- Who are the founders of CapsuLINT?
- The founders of CapsuLINT are Alon Blankstein, Allan Aginsky, and Dr. Doron Friedman.
- What specific product is mentioned in relation to CapsuLINT's technology?
- CapsuLINT's product development includes Docetaxel.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
drug-deliverytherapeuticspharmaceuticalsoral-drugs